Hypersensitivity	hypersensitivity	O	DISEASE	OTHERS	I
myocarditis	myocarditis	O	DISEASE	OTHERS	I
complicating	complicating	O	O	O	O
hypertrophic	hypertrophic	O	O	OTHERS	I
cardiomyopathy	cardiomyopathy	O	DISEASE	OTHERS	I
heart	heart	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
present	present	O	O	O	O
report	report	O	O	O	O
describes	describes	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
eosinophilic	eosinophilic	O	O	OTHERS	I
myocarditis	myocarditis	O	DISEASE	OTHERS	I
complicating	complicating	O	O	O	O
hypertrophic	hypertrophic	O	O	OTHERS	I
cardiomyopathy	cardiomyopathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
47-year-old	47-year-old	O	O	O	O
female	female	O	O	O	O
patient	patient	O	O	O	O
,	,	O	O	O	O
known	known	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
hypertrophic	hypertrophic	O	O	OTHERS	I
cardiomyopathy	cardiomyopathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
was	was	O	O	O	O
admitted	admitted	O	O	O	O
with	with	O	O	O	O
biventricular	biventricular	O	O	OTHERS	I
failure	failure	O	O	OTHERS	I
and	and	O	O	O	O
managed	managed	O	O	O	O
aggressively	aggressively	O	O	O	O
with	with	O	O	O	O
dobutamine	dobutamine	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
and	and	O	O	O	O
other	other	O	O	O	O
drugs	drugs	O	O	O	O
while	while	O	O	O	O
being	being	O	O	O	O
assessed	assessed	O	O	O	O
for	for	O	O	O	O
heart	heart	O	O	O	O
transplantation	transplantation	O	O	O	O
.	.	O	O	O	O

On	on	O	O	O	O
transthoracic	transthoracic	O	O	O	O
echocardiogram	echocardiogram	O	O	O	O
,	,	O	O	O	O
she	she	O	O	O	O
had	had	O	O	O	O
moderate	moderate	O	O	O	O
left	left	O	O	OTHERS	I
ventricular	ventricular	O	DISEASE	OTHERS	I
dysfunction	dysfunction	O	DISEASE	OTHERS	I
with	with	O	O	O	O
regional	regional	O	O	O	O
variability	variability	O	O	O	O
and	and	O	O	O	O
moderate	moderate	O	O	O	O
mitral	mitral	O	DISEASE	OTHERS	I
regurgitation	regurgitation	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
recipient	recipient	O	O	O	O
's	's	O	O	O	O
heart	heart	O	O	O	O
showed	showed	O	O	O	O
the	the	O	O	O	O
features	features	O	O	O	O
of	of	O	O	O	O
apical	apical	O	O	O	O
hypertrophic	hypertrophic	O	O	OTHERS	I
cardiomyopathy	cardiomyopathy	O	DISEASE	OTHERS	I
and	and	O	O	O	O
myocarditis	myocarditis	O	DISEASE	OTHERS	I
with	with	O	O	O	O
abundant	abundant	O	O	O	O
eosinophils	eosinophils	O	O	O	O
.	.	O	O	O	O

Myocarditis	myocarditis	O	DISEASE	OTHERS	I
is	is	O	O	O	O
rare	rare	O	O	O	O
and	and	O	O	O	O
eosinophilic	eosinophilic	O	O	OTHERS	I
myocarditis	myocarditis	O	DISEASE	OTHERS	I
is	is	O	O	O	O
rarer	rarer	O	O	O	O
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
likely	likely	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
hypersensitivity	hypersensitivity	O	DISEASE	OTHERS	I
(	(	O	O	O	O
eosinophilic	eosinophilic	O	O	OTHERS	I
)	)	O	O	O	O
myocarditis	myocarditis	O	DISEASE	OTHERS	I
was	was	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
dobutamine	dobutamine	CHEMICALS	O	OTHERS	I
infusion	infusion	O	O	O	O
therapy	therapy	O	O	O	O
.	.	O	O	O	O

Eosinophilic	eosinophilic	O	O	OTHERS	I
myocarditis	myocarditis	O	DISEASE	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
incidence	incidence	O	O	O	O
of	of	O	O	O	O
2.4	2.4	O	O	O	O
%	%	O	O	O	O
to	to	O	O	O	O
7.2	7.2	O	O	O	O
%	%	O	O	O	O
in	in	O	O	O	O
explanted	explanted	O	O	O	O
hearts	hearts	O	O	O	O
and	and	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
multidrug	multidrug	O	O	O	O
therapy	therapy	O	O	O	O
.	.	O	O	O	O

